Search results

Selected filters:

Finance
United States of America

Article type

Topic

Sector

167 results found for your search

Sort options
14 March 2019

New research highlights impact of patent eligibility uncertainty on life sciences and tech investments

Academic calls for Congress to act on 101 “to restore investor confidence” with private equity and VC players clear that doubts over patentability make it less likely they will part with cash

07 March 2019

Lone inventor takes on Huawei in case that exposes the deep disparities in the US patent system

Portuguese national says he has sold his house to hire an attorney to go after the Chinese company over alleged IP theft – a huge leap of faith given US assertion realities

21 February 2019

Burford takes aim at opioid overdose medication in series of IPRs

Reviews challenge validity of patents owned by Opiant Pharmaceuticals relating to Narcan brand of naloxone as price of treatments rises

19 February 2019

New Acacia chief IP officer charts a different course for the once mighty NPE

Supported by a healthy balance sheet, Marc Booth says the firm plans on a higher volume of smaller deals with three new areas identified for future growth

13 February 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco 

12 February 2019

New investment platform aims to break down barriers to capital for innovators

Former IV unit teams up with alternative asset business to give large and small innovators way of attracting finance on Blockchain-based initiative

28 January 2019

Critical condition: has Section 101 put the US medical device sector on life support?

As fears grow over subject-matter eligibility and technological convergence threatens to reshape the competitive landscape, patent strategy has become even more crucial for medical device companies

26 January 2019

Taylor Swift rewrites the rules for licensing

The singer-songwriter is using her industry clout to secure an unprecedented record deal that will also improve the streaming-related revenue of fellow artists.

22 January 2019

Blockchain startup’s new tack reveals much about what IP managers need most

Operem is still working toward building a blockchain platform for patent trading, but its first product reflects demand for tools that enable open innovation efforts and trade secret protection

14 January 2019

Five takeaways from China’s 2018 patent stats

Patent office officials in Beijing reveal the country's top patent recipients, amount of cross-border royalty flows and ambiguous data on foreign firms' patenting activity

28 November 2018

Is McCurdy the man to rescue RPX?

Just months after a private equity takeover, RPX has appointed an industry veteran as its new CEO. But with a declining financial performance and questions remaining over the future of its discovery business, Dan McCurdy (left) will need all of his experience to turn around one of the patent market’s most iconic businesses.

12 November 2018

IP portfolio at stake in fight between EV startup and Chinese investor

Faraday Future says its biggest backer, a Chinese property developer, is deliberately driving it into bankruptcy in order to acquire collateralised intellectual property in a ‘fire sale’.

16 October 2018

After McCurdy’s exit, Provenance rethinks its strategy

“There’s no question that asserting is an option,” says new CEO Lynch

28 September 2018

McCurdy's move to RPX is high stakes for himself and for the firm

The defensive aggregator's new CEO is a much-needed figurehead, but with litigation risk in the US diminishing the former Provenance head faces some serious challenges

13 September 2018

Fortress’s burgeoning IP group adds Tivo patent dealmaker

The hire of Courtney Quish and the closing of an investment fund thought to be close to $1 billion in value adds even more heft to the team headed by Eran Zur